doi: 10.1186/s12891-022-05396-5 Summary Keywords type 2 diabetes, osteoporosis, GLP-1 receptor agonists, electronic medical records, cohort study, bone metabolism, fracture risk Citation Chen M, Lyu Y, Zhao J, Han X, Huang T, Yang T and Zhou Y (2025) Use of GLP-1 receptor agonist and risk of osteoporosis among patients with type 2 diabetes: a real-world study
People switching from tirzepatide to semaglutide need to understand these differences to avoid dangerous dosing translations between the two medications
Wu Z, et al
For acute hives that do not improve within a day or two, a doctor may recommend higher doses or prescription options
Remember, you ingested it orally